Cartesian Therapeutics, Inc.
RNAC
Last
$7.06
Day
+3.4%
1y
-32.5%
5y
-78.8%
52w
-38.0%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-0525d
EMA 21
7.50
EMA 50
8.04
EMA 200
8.40
20d high
-18.0%
5y high
-84.0%
5y range
3th
Positions held
Your positionsRNAC isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-24
Hold
avoid
Signal
Strong Sell
Target
$7.56
Stop
$6.21
Stop distance
12.0%
Target vs last
+7.2%
Fundamentals
| Market cap | $206.34M | Enterprise value | $122.59M | Trailing P/E | — | Forward P/E | -1.79 |
| PEG | — | Price / book | -1.64 | Beta | 0.72 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | -8.0% | Gross margin | 0.0% | Operating margin | -66.8% |
| Profit margin | 0.0% | ROE | — | ROA | -17.4% | Debt / equity | — |
| Current ratio | 7.48 | Free cash flow | -$47.48M | Analyst recommendation | strong_buy | Mean target | $33.67 |
| 52w high | $11.00 | 52w low | $5.60 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.1M | $0.9M | $0.5M | $0.3M | — |
| Op margin | — | -33973.1% | -2316.7% | -4660.6% | -7319.1% | — |
| Net income | $15.8M | -$39.2M | -$92.6M | -$35.9M | $15.9M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$29.2M | -$26.5M | -$21.9M | -$21.1M | -$21.8M | — |
- Revenue -100% vs prior quarter ($0 vs $0.1M).
- Operating margin compressed to -33973.1%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $2.8M | $38.9M | $26.0M | $111M | — |
| Op margin | -3099.9% | -93.3% | -329.6% | 13.1% | — |
| Net income | -$130M | -$77.4M | -$220M | $35.4M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$86.7M | -$36.3M | -$85.7M | $14.5M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-02 · Cartesian Therapeutics Announces New Employment Inducement Grants
2026-09-08 · Cartesian Therapeutics Announces New Employment Inducement Grants
2026-09-03 · Cartesian Therapeutics to Participate in Upcoming Investor Conferences
2026-08-07 · Cartesian Therapeutics Announces New Employment Inducement Grants
2026-08-06 · Cartesian Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Price (daily)
Full chart · RSI · MACD · patternsRNAC · daily-15.6% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin